|
- 2018
CorrigendumDOI: 10.1080/15384047.2017.1418249 Abstract: May C, Landers SM, Bolshakov S, Ma X, Ingram DR, Kivlin CM, Watson KL, Al-Sannaa G, Bhalla AD, Wang W, Lazar AJ, Torres KE. Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma. Cancer Biol Ther. 2017;18(10), 747–826. doi:10.1080/15384047.2017.137323
|